The move halts several pilot programs, including offering Medicare Part D recipients generic medications for a $2 copay.

Trump reversed a Biden order that sought to lower drug prices and make gene and cell therapies for cancer and other disease treatment available to Medicaid patients.

President Trump rescinded an executive order that prompted the creation of three Medicare drug-pricing experiments ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...